almonertinib

Key facts

Mechanism of action

Epidermal growth factor receptor erbB1 inhibitor

Primary target: Epidermal growth factor receptor

Approval history

1. Almonertinib Phase 3 · Chinese Academy of · Non-small Cell Lung Cancer Metastatic
2. Almonertinib Phase 2 · Sun Yat-sen University · Safety of Almonertinib
3. Almonertinib Phase 2 · First People's Hospital · Non Small Cell Lung Cancer
4. Almonertinib Phase 2 · Chinese Academy of · Lung Cancer Non-small Cell Stage IV
5. Almonertinib Phase 2 · First People's Hospital · EGFR Positive Non-small Cell Lung Cancer
6. Almonertinib Phase 2 · Chinese Academy of · Non-small Cell Lung Cancer
7. Almonertinib 110 MG Phase 2 · Chinese University of · Rare Tumor

1. erlotinib hydrochloride Epidermal growth factor receptor erbB1 inhibitor
2. lapatinib ditosylate Receptor protein-tyrosine kinase erbB-2 inhibitor
3. mobocertinib Antineoplastic and immunomodulating agents (L01)
4. mobocertinib succinate Epidermal growth factor receptor erbB1 inhibitor
5. neratinib maleate Receptor protein-tyrosine kinase erbB-2 inhibitor
6. afatinib dimaleate Epidermal growth factor receptor erbB1 inhibitor

Frequently asked questions